Proliferative capacity in head and neck cancer

✍ Scribed by Henk Struikmans; Henk B. Kal; Gert J. Hordijk; Ingeborg van der Tweel

• Publisher: John Wiley and Sons
• Year: 2001
• Tongue: English
• Weight: 90 KB
• Volume: 23
• Category: Article
• ISSN: 1043-3074
• DOI: 10.1002/hed.1064

✦ Synopsis

Abstract

Background

Shortening of overall treatment time (accelerated radiotherapy) appears to result in an increase of the efficacy of irradiation. In this study, we compared the proliferative capacity between tumors originating in different sites of the head and neck region. Tumors with a large proliferating capacity might, theoretically, benefit most from accelerated radiotherapy.

Material and Methods

BrdUrd was administered intravenously in patients with head and neck carcinomas. Tumor samples were analyzed with flow cytometry. T and N stages were assessed in accordance with the TNM classification system (UICC 1987).

Results

No significant differences in proliferation parameters were observed with respect to site of origin of head and neck tumors. For T3/T4 tumors, DNA ploidy is an important tumor characteristic: G1‐ and S‐phase fractions, labeling index, and tumor doubling time Tpot differences were statistically significant; the aneuploid tumors showed the largest proliferative potential.

Conclusions

(1) In general, no significant differences in proliferation parameters were observed with respect to site of origin. (2) Aneuploid head and neck tumors have a higher proliferative capacity than diploid ones, they might benefit most from accelerated irradiation. © 2001 John Wiley & Sons, Inc. Head Neck 23: 484–491, 2001